Literature DB >> 17456543

Managing complex medication regimens: perspectives of consumers with osteoarthritis and healthcare professionals.

Elizabeth Manias1, Kate Claydon-Platt, Geoffrey J McColl, Tracey K Bucknall, Caroline A Brand.   

Abstract

BACKGROUND: Managing medications is complex, particularly for consumers with multiple coexisting conditions for whom benefits and adverse effects are unpredictable and health priorities may be variable.
OBJECTIVE: To investigate perceptions of and experiences with managing drug regimens from the perspectives of consumers with osteoarthritis and coexisting chronic conditions and of healthcare professionals from diverse backgrounds.
METHODS: Using an exploratory research design, focus groups were formed with 34 consumers and 19 healthcare professionals. Individual interviews were undertaken with 3 community medical practitioners.
RESULTS: Consumers' management of medications was explored in terms of 3 themes: administration of medications, provision of information, and the perceived role of healthcare professionals. In general, consumers lacked understanding regarding the reason that they were prescribed certain medications. Since all consumer participants had at least 2 chronic conditions, they were taking many drugs to relieve undesirable symptoms. Some consumers were unable to achieve improved pain relief and were reluctant to take analgesics prescribed on an as-needed basis. Healthcare professionals discussed the importance of using non-pharmacologic measures to improve symptoms; however, consumers stated that physicians encourage them to continue using medications, often for prolonged periods, even when these agents are not helpful.
CONCLUSIONS: Consumers were dissatisfied about the complexity of their medication regimens and also lacked understanding as to how to take their drugs effectively. Dedicated time should be devoted during medical consultations to facilitate verbal exchange of information about medications. Pharmacists must communicate regularly with physicians about consumers' medication needs to help preempt any problems that may arise. Instructions need to be revised through collaboration between physicians and pharmacists so that "as needed" directions provide more explicit advice about when and how to use such drugs. Future research, using large, generalizable samples, should examine trends related to consumers' experiences of symptomatic relief from chronic conditions and their understandings about medications.

Entities:  

Mesh:

Year:  2007        PMID: 17456543     DOI: 10.1345/aph.1H623

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  16 in total

1.  Quantifying the medication burden of kidney transplant recipients in the first year post-transplantation.

Authors:  Jac Kee Low; Kimberley Crawford; Elizabeth Manias; Allison Williams
Journal:  Int J Clin Pharm       Date:  2018-06-28

Review 2.  The Challenges of Treating Sciatica Pain in Older Adults.

Authors:  Manuela L Ferreira; Andrew McLachlan
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

3.  Impact of an intervention to reduce medication regimen complexity for older hospital inpatients.

Authors:  Rohan A Elliott; Christopher O'Callaghan; Eldho Paul; Johnson George
Journal:  Int J Clin Pharm       Date:  2012-12-05

4.  Multi-stakeholder collaboration in the redesign of family-centered rounds process.

Authors:  Anping Xie; Pascale Carayon; Randi Cartmill; Yaqiong Li; Elizabeth D Cox; Julie A Plotkin; Michelle M Kelly
Journal:  Appl Ergon       Date:  2014-08-12       Impact factor: 3.661

Review 5.  Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

Authors:  Joanne Reeve; Michelle Maden; Ruaraidh Hill; Amadea Turk; Kamal Mahtani; Geoff Wong; Dan Lasserson; Janet Krska; Dee Mangin; Richard Byng; Emma Wallace; Ed Ranson
Journal:  Health Technol Assess       Date:  2022-07       Impact factor: 4.106

Review 6.  Translating evidence into practice for people with osteoarthritis of the hip and knee.

Authors:  Caroline Brand
Journal:  Clin Rheumatol       Date:  2007-05-05       Impact factor: 3.650

7.  Older adults with multi-morbidity: medication management processes and design implications for personal health applications.

Authors:  Leah M Haverhals; Courtney A Lee; Katie A Siek; Carol A Darr; Sunny A Linnebur; J Mark Ruscin; Stephen E Ross
Journal:  J Med Internet Res       Date:  2011-06-29       Impact factor: 5.428

8.  The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia.

Authors:  Wen Wei Chung; Siew Siang Chua; Pauline Siew Mei Lai; Donald E Morisky
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 9.  Patient capacity and constraints in the experience of chronic disease: a qualitative systematic review and thematic synthesis.

Authors:  Kasey R Boehmer; Michael R Gionfriddo; Rene Rodriguez-Gutierrez; Abd Moain Abu Dabrh; Aaron L Leppin; Ian Hargraves; Carl R May; Nathan D Shippee; Ana Castaneda-Guarderas; Claudia Zeballos Palacios; Pavithra Bora; Patricia Erwin; Victor M Montori
Journal:  BMC Fam Pract       Date:  2016-09-01       Impact factor: 2.497

10.  Cross-sectional examination of musculoskeletal conditions and multimorbidity: influence of different thresholds and definitions on prevalence and association estimates.

Authors:  Dianne B Lowe; Michael J Taylor; Sophie J Hill
Journal:  BMC Res Notes       Date:  2017-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.